PMID: 11918647Mar 29, 2002Paper

The medical management of spasticity

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
G Abbruzzese

Abstract

When spasticity produces a clinical disability by interfering with posture, motor capacity, nursing or daily living activities, medical treatment is recommended. It is mainly indicated when the muscle overactivity is diffusely distributed and should be implemented early, to prevent permanent musculoskeletal deformities or contractures. A pharmacological approach relies on the use of drugs which modulate neurotransmitters acting at the cortico-spinal level (GABA, glycine, glutamate, noradrenaline, serotonin). The aim of this treatment is to decrease spinal reflex excitability by reducing the release of excitatory neurotransmitters, or by potentiating the activity of inhibitory inputs. Evaluation of the efficacy of these drugs is determined by the therapeutic objectives which may be biomechanical, or functional. Diazepam increases presynaptic inhibition by stimulating GABA(A) receptors in the brainstem and spinal cord. In double-blind studies of patients with spinal cord lesions, antispastic efficacy has been shown, but side-effects are common. Baclofen stimulates GABA(B) receptors inducing a suppression of excitatory neurotransmitter release. Antispastic efficacy is sufficiently documented, but no definite effects on ambulation ...Continue Reading

References

Oct 16, 1987·Pharmaceutisch Weekblad. Scientific Edition·E W Wuis
Sep 1, 1974·Journal of the Neurological Sciences·N E CartlidgeD Weightman
Jan 1, 1964·Annals of Physical Medicine·C A Simpson
Oct 1, 1994·Journal of Pain and Symptom Management·H J Waldman
Nov 14, 1997·The Journal of Spinal Cord Medicine·C P BroderickW A Bauman
Nov 3, 1998·American Journal of Physical Medicine & Rehabilitation·A Dunevsky, A B Perel
May 5, 2000·The Cochrane Database of Systematic Reviews·M TariccoE Telaro
Mar 29, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·G Sheean

❮ Previous
Next ❯

Citations

May 27, 2009·Experimental Brain Research·Maria KnikouSusan J Harkema
Jan 17, 2012·Neurocritical Care·Benjamin BergerThorsten Steiner
Mar 9, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Alexander G Rabchevsky, Patrick H Kitzman
Mar 29, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Y LazorthesJ-C Verdié
Jan 8, 2010·Neurorehabilitation and Neural Repair·Hatice KumruAlvaro Pascual-Leone
Mar 1, 2006·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Predrag PerićStojanka Arsić
Nov 1, 2012·Pain Management·Michael Saulino
Mar 16, 2011·Journal of Aging Research·Jennifer K CooneyJeanette M Thom
Oct 30, 2009·The International Journal of Neuroscience·Maria KnikouSusan J Harkema
Jun 8, 2012·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Fode Abass CisseJean-Philippe Camdessanche
Jun 21, 2011·Experimental Neurology·Maria Knikou, Chaithanya K Mummidisetty
Sep 23, 2009·PM & R : the Journal of Injury, Function, and Rehabilitation·Gerard E FranciscoMichael Turner
Aug 22, 2007·Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology·Isabella CampaniniDario Farina
Jul 20, 2007·Lancet Neurology·Volker Dietz, Thomas Sinkjaer
Jun 28, 2005·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Antonio Nardone, Marco Schieppati
Feb 22, 2012·Experimental Neurology·Roland R Roy, V Reggie Edgerton
Jun 19, 2013·European Addiction Research·Roberta AgabioGian Luigi Gessa
Apr 4, 2013·Stereotactic and Functional Neurosurgery·Bunpot SitthinamsuwanTeerada Ploypetch
Nov 24, 2016·Neurological Research·Jing WangMingyue Xiao
Dec 11, 2014·Journal of Addiction Medicine·Rama M KamalCornelis A J De Jong
Mar 2, 2018·Current Medical Research and Opinion·Mireia Raluy-CalladoSylvie Gabriel
Jan 31, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·L CsibaA B Guekht
May 13, 2003·The Veterinary Record·H NolletP Deprez
Jun 27, 2009·Brain Injury : [BI]·Noureddin Nakhostin AnsariMaryam Rastgoo
Jan 25, 2018·Current Diabetes Reports·Corinne Lee-KubliNigel A Calcutt
Jan 25, 2020·Journal of Occupational and Environmental Medicine·Kurt T HegmannJeffrey S Harris
Jun 14, 2003·The Cochrane Database of Systematic Reviews·M W van TulderL M Bouter
Aug 18, 2016·Drugs·Yvette N Lamb, Lesley J Scott
Dec 20, 2017·Journal of Medical Engineering & Technology·Fan-Zhe LowChen-Hua Yeow
Dec 16, 2020·Neurology India·Johnie O HodgeNicholas J Brandmeir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
G Sheean
© 2022 Meta ULC. All rights reserved